kuvura atari kanseri y'ibihaha ntoya

kuvura atari kanseri y'ibihaha ntoya

Gusobanukirwa no kuvura Kanseri y'ibihaha itari nto

Aka gatabo kasesenguye kanseri y'ibihaha itari ntoya (NSCLC), ubwoko bwa kanseri y'ibihaha ikunze kugaragara. Twinjiye mubisuzumwa byayo, bitandukanye kuvura kanseri y'ibihaha itari ntoya amahitamo, n'akamaro ko gutahura hakiri kare no kwita kubantu kugiti cyabo. Wige ibijyanye niterambere rigezweho mubuyobozi bwa NSCLC nibikoresho bihabwa abarwayi nimiryango yabo.

Gusobanukirwa Kanseri y'ibihaha itari ntoya (NSCLC)

NSCLC ni iki?

Kanseri y'ibihaha itari ntoya igizwe na 85% by'indwara zose za kanseri y'ibihaha. Irangwa no gukura kudasanzwe kwingirabuzimafatizo mu bihaha, zishobora gukwirakwira mu bindi bice byumubiri (metastasis). Ubwoko butandukanye burahari, buri kimwe gifite ibimenyetso byihariye bigira ingaruka kuvura kanseri y'ibihaha itari ntoya ingamba. Kumenya hakiri kare bitezimbere cyane ibisubizo byubuvuzi.

Ibintu bishobora guteza ingaruka kuri NSCLC

Ibintu byinshi byongera ibyago byo kwandura NSCLC, harimo kunywa itabi (impamvu nyamukuru), guhura na asibesitosi nizindi kanseri, amateka yumuryango wa kanseri yibihaha, hamwe nubuzima bumwe na bumwe. Gusobanukirwa izi ngaruka ni ngombwa mu ngamba zo gukumira no gusuzuma hakiri kare.

Gusuzuma NSCLC

Kwipimisha mubisanzwe bikubiyemo guhuza ibizamini byerekana amashusho (nk'igituza X-imirasire, CT scan, na PET scan), biopsy (gusuzuma ingero z'umubiri), no gupima amaraso. Icyiciro cya kanseri (uko imaze gukwirakwira) ni ngombwa mu kumenya igikwiye kuvura kanseri y'ibihaha itari ntoya gahunda.

Amahitamo yo kuvura NSCLC

Kubaga

Kubyiciro byambere NSCLC, kubagwa kugirango ukureho ikibyimba cya kanseri birashobora guhitamo. Ubwoko bwo kubaga biterwa n'ubunini n'aho ikibyimba giherereye. Tekinike yo kubaga byibura ikoreshwa kenshi kugirango igabanye igihe cyo gukira.

Chimoterapi

Chimoterapi ikoresha imiti yica kanseri. Bikunze gukoreshwa mukuvura NSCLC yateye imbere, akenshi ifatanije nubundi buvuzi nka therapy target cyangwa immunotherapy. Ingaruka zinyuranye ziratandukanye bitewe nibiyobyabwenge byihariye bikoreshwa.

Ubuvuzi

Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango isenye kanseri. Irashobora gukoreshwa mbere yo kubagwa (neoadjuvant) kugirango igabanye ikibyimba, nyuma yo kubagwa (adjuvant) kwica selile zose zisigaye za kanseri, cyangwa nkibanze kuvura kanseri y'ibihaha itari ntoya ku barwayi batari abakandida babaga.

Ubuvuzi bugamije

Imiti igamije kuvura yibanda kuri molekile yihariye igira uruhare mu mikurire ya kanseri. Ubu buvuzi bufite akamaro kanini kubarwayi ba NSCLC bafite ihindagurika ryimiterere. Kwipimisha buri gihe kugirango ukurikirane ihinduka ryimiterere ni ngombwa kubantu kugiti cyabo kuvura kanseri y'ibihaha itari ntoya.

Immunotherapy

Immunotherapy ikoresha imbaraga z'umubiri zo kurwanya kanseri. Nuburyo butanga ikizere kuri NSCLC yateye imbere, ikoreshwa kenshi hamwe nubundi buvuzi. Ingaruka zuruhande zirashobora kuba zirimo ubudahangarwa bujyanye nibintu bibi.

Ubuvuzi buhanitse hamwe nigeragezwa rya Clinical

Umwanya wa NSCLC kuvura kanseri y'ibihaha itari ntoya ihora ihindagurika. Ubuvuzi buhanitse, nka CAR T-selile yubuvuzi nubundi buryo bushya, burimo gukorwa iperereza mubigeragezo byamavuriro. Kwitabira ibizamini byamavuriro bitanga uburyo bwo kuvura bigezweho kandi bigira uruhare mu iterambere mu bushakashatsi bwa kanseri. Kumakuru yerekeye ibizamini byamavuriro, urashobora kubaza ibikoresho nkikigo cyigihugu cya kanseri (https://www.cancer.gov/).

Ubuvuzi bwihariye mubuvuzi bwa NSCLC

Abadozi b'imiti yihariye kuvura kanseri y'ibihaha itari ntoya ingamba zishingiye kumiterere yumuntu ku giti cye, ibiranga ibibyimba, nubuzima muri rusange. Kwipimisha genetike bigira uruhare runini mu kuyobora ibyemezo byo kuvura no kuvura neza. Ikigo cy'ubushakashatsi cya Kanseri ya Shandong Baofa (https://www.baofahospital.com/) yitangiye gutanga kanseri yateye imbere, ikoresha ibishya mubuvuzi bwihariye.

Kwitaho hamwe nibikoresho

Kubana na NSCLC birashobora kuba ingorabahizi, haba kumubiri no mumarangamutima. Ubuvuzi bufasha bwibanda ku kuzamura imibereho binyuze mu gucunga ububabare, infashanyo zimirire, ubujyanama bwamarangamutima, nibindi bikoresho. Amatsinda yo gufasha abarwayi hamwe nabaturage kumurongo barashobora gutanga inkunga yingirakamaro kandi yingirakamaro.

Incamake

Gucunga neza NSCLC bisaba uburyo butandukanye burimo abaganga ba oncologue, kubaga, radiotherapiste, nabandi bashinzwe ubuzima. Kumenya hakiri kare, kugiti cye kuvura kanseri y'ibihaha itari ntoya, kandi ubuvuzi bwuzuye bufasha ningirakamaro mugutezimbere ibyagezweho nubuzima bwiza kubantu basuzumwe niyi ndwara. Wibuke kugisha inama abashinzwe ubuzima kugirango baguhe inama hamwe na gahunda yo kuvura.

Bifitanye isano ibicuruzwa

Ibicuruzwa bifitanye isano

Kugurisha neza ibicuruzwa

Ibicuruzwa byiza cyane
Murugo
Imanza zisanzwe
Ibyerekeye Twebwe
Twandikire

Nyamuneka udusigire ubutumwa